img

Global Medicines for Eosinophilic Asthma Treatment Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Medicines for Eosinophilic Asthma Treatment Market Insights, Forecast to 2034

Eosinophilic asthma is a type of asthma that is caused by high levels of white blood cells called eosinophils in the airways of the lungs.
Market Analysis and InsightsGlobal Medicines for Eosinophilic Asthma Treatment Market
Global Medicines for Eosinophilic Asthma Treatment market is expected to reach to US$ million in 2024, with a positive growth of %, compared with US$ million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Medicines for Eosinophilic Asthma Treatment industry is evaluated to reach US$ million in 2029. The CAGR will be % during 2024 to 2029.
Globally, Medicines for Eosinophilic Asthma Treatment key companies include AstraZeneca, GSK, Genentech (Roche Group) & Novartis, Regeneron Pharmaceuticals & Sanofi and Teva Pharmaceuticals, etc. AstraZeneca, GSK, Genentech (Roche Group) & Novartis are top 3 players and held % share in total in 2022.
When considering the consumption regions, % revenue of Medicines for Eosinophilic Asthma Treatment were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029 and the share will be % in 2029. Moreover, China, plays a key role in the whole Medicines for Eosinophilic Asthma Treatment market and estimated to attract more attentions from industry insiders and investors.
Medicines for Eosinophilic Asthma Treatment can be divided into Fasenra, Nucala, Cinqair and Others, etc. Fasenra is the mainstream product in the market, accounting for % revenue share globally in 2022 and the proportion will be % in 2029.
Medicines for Eosinophilic Asthma Treatment is widely used in various fields, such as Children, Adults and Teenagers,, etc. Children provides greatest supports to the Medicines for Eosinophilic Asthma Treatment industry development. In 2022, global % revenue of Medicines for Eosinophilic Asthma Treatment went into Children filed and the proportion will reach to % in 2029.
Report Covers
This report presents an overview of global Medicines for Eosinophilic Asthma Treatment market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Medicines for Eosinophilic Asthma Treatment market with multiple angles. Items like regional revenue from 2018 to 2029 and companies’ revenue and gross margin from 2018 to 2024 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


AstraZeneca
GSK
Genentech (Roche Group) & Novartis
Regeneron Pharmaceuticals & Sanofi
Teva Pharmaceuticals
Segment by Type
Fasenra
Nucala
Cinqair
Others

Segment by Application


Children
Adults
Teenagers
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2029
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2029 globally
Chapter 5Product revenue analysis by application from 2018 to 2029 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2029 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product revenue analysis by type and application from 2018 to 2029 in Europe. Product revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product revenue analysis by type and application from 2018 to 2029 in China. Product revenue analysis of China from 2018 to 2029
Chapter 9Product revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Companies’ outline, covering company’s basic information, major business, Medicines for Eosinophilic Asthma Treatment introduction, etc. Medicines for Eosinophilic Asthma Treatment Revenue and Gross Margin of each company from 2018 to 2024
Chapter 12Mr Accuracy reports Conclusions of Medicines for Eosinophilic Asthma Treatment
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Medicines for Eosinophilic Asthma Treatment Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Fasenra
1.2.3 Nucala
1.2.4 Cinqair
1.2.5 Others
1.3 Market by Application
1.3.1 Global Medicines for Eosinophilic Asthma Treatment Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Children
1.3.3 Adults
1.3.4 Teenagers
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Medicines for Eosinophilic Asthma Treatment Market Perspective (2018-2029)
2.2 Global Medicines for Eosinophilic Asthma Treatment Growth Trends by Region
2.2.1 Medicines for Eosinophilic Asthma Treatment Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Medicines for Eosinophilic Asthma Treatment Historic Market Size by Region (2018-2024)
2.2.3 Medicines for Eosinophilic Asthma Treatment Forecasted Market Size by Region (2024-2029)
2.3 Medicines for Eosinophilic Asthma Treatment Market Dynamics
2.3.1 Medicines for Eosinophilic Asthma Treatment Industry Trends
2.3.2 Medicines for Eosinophilic Asthma Treatment Market Drivers
2.3.3 Medicines for Eosinophilic Asthma Treatment Market Challenges
2.3.4 Medicines for Eosinophilic Asthma Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Medicines for Eosinophilic Asthma Treatment by Players
3.1.1 Global Medicines for Eosinophilic Asthma Treatment Revenue by Players (2018-2024)
3.1.2 Global Medicines for Eosinophilic Asthma Treatment Revenue Market Share by Players (2018-2024)
3.2 Global Medicines for Eosinophilic Asthma Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Medicines for Eosinophilic Asthma Treatment, Ranking by Revenue, 2021 VS 2022 VS 2024
3.4 Global Medicines for Eosinophilic Asthma Treatment Market Concentration Ratio
3.4.1 Global Medicines for Eosinophilic Asthma Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Medicines for Eosinophilic Asthma Treatment Revenue in 2022
3.5 Global Key Players of Medicines for Eosinophilic Asthma Treatment Head office and Area Served
3.6 Global Key Players of Medicines for Eosinophilic Asthma Treatment, Product and Application
3.7 Global Key Players of Medicines for Eosinophilic Asthma Treatment, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Medicines for Eosinophilic Asthma Treatment Breakdown Data by Type
4.1 Global Medicines for Eosinophilic Asthma Treatment Historic Market Size by Type (2018-2024)
4.2 Global Medicines for Eosinophilic Asthma Treatment Forecasted Market Size by Type (2024-2029)
5 Medicines for Eosinophilic Asthma Treatment Breakdown Data by Application
5.1 Global Medicines for Eosinophilic Asthma Treatment Historic Market Size by Application (2018-2024)
5.2 Global Medicines for Eosinophilic Asthma Treatment Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Medicines for Eosinophilic Asthma Treatment Market Size (2018-2029)
6.2 North America Medicines for Eosinophilic Asthma Treatment Market Size by Type
6.2.1 North America Medicines for Eosinophilic Asthma Treatment Market Size by Type (2018-2024)
6.2.2 North America Medicines for Eosinophilic Asthma Treatment Market Size by Type (2024-2029)
6.2.3 North America Medicines for Eosinophilic Asthma Treatment Market Share by Type (2018-2029)
6.3 North America Medicines for Eosinophilic Asthma Treatment Market Size by Application
6.3.1 North America Medicines for Eosinophilic Asthma Treatment Market Size by Application (2018-2024)
6.3.2 North America Medicines for Eosinophilic Asthma Treatment Market Size by Application (2024-2029)
6.3.3 North America Medicines for Eosinophilic Asthma Treatment Market Share by Application (2018-2029)
6.4 North America Medicines for Eosinophilic Asthma Treatment Market Size by Country
6.4.1 North America Medicines for Eosinophilic Asthma Treatment Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Medicines for Eosinophilic Asthma Treatment Market Size by Country (2018-2024)
6.4.3 North America Medicines for Eosinophilic Asthma Treatment Market Size by Country (2024-2029)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Medicines for Eosinophilic Asthma Treatment Market Size (2018-2029)
7.2 Europe Medicines for Eosinophilic Asthma Treatment Market Size by Type
7.2.1 Europe Medicines for Eosinophilic Asthma Treatment Market Size by Type (2018-2024)
7.2.2 Europe Medicines for Eosinophilic Asthma Treatment Market Size by Type (2024-2029)
7.2.3 Europe Medicines for Eosinophilic Asthma Treatment Market Share by Type (2018-2029)
7.3 Europe Medicines for Eosinophilic Asthma Treatment Market Size by Application
7.3.1 Europe Medicines for Eosinophilic Asthma Treatment Market Size by Application (2018-2024)
7.3.2 Europe Medicines for Eosinophilic Asthma Treatment Market Size by Application (2024-2029)
7.3.3 Europe Medicines for Eosinophilic Asthma Treatment Market Share by Application (2018-2029)
7.4 Europe Medicines for Eosinophilic Asthma Treatment Market Size by Country
7.4.1 Europe Medicines for Eosinophilic Asthma Treatment Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Medicines for Eosinophilic Asthma Treatment Market Size by Country (2018-2024)
7.4.3 Europe Medicines for Eosinophilic Asthma Treatment Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Medicines for Eosinophilic Asthma Treatment Market Size (2018-2029)
8.2 China Medicines for Eosinophilic Asthma Treatment Market Size by Type
8.2.1 China Medicines for Eosinophilic Asthma Treatment Market Size by Type (2018-2024)
8.2.2 China Medicines for Eosinophilic Asthma Treatment Market Size by Type (2024-2029)
8.2.3 China Medicines for Eosinophilic Asthma Treatment Market Share by Type (2018-2029)
8.3 China Medicines for Eosinophilic Asthma Treatment Market Size by Application
8.3.1 China Medicines for Eosinophilic Asthma Treatment Market Size by Application (2018-2024)
8.3.2 China Medicines for Eosinophilic Asthma Treatment Market Size by Application (2024-2029)
8.3.3 China Medicines for Eosinophilic Asthma Treatment Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Medicines for Eosinophilic Asthma Treatment Market Size (2018-2029)
9.2 Asia Medicines for Eosinophilic Asthma Treatment Market Size by Type
9.2.1 Asia Medicines for Eosinophilic Asthma Treatment Market Size by Type (2018-2024)
9.2.2 Asia Medicines for Eosinophilic Asthma Treatment Market Size by Type (2024-2029)
9.2.3 Asia Medicines for Eosinophilic Asthma Treatment Market Share by Type (2018-2029)
9.3 Asia Medicines for Eosinophilic Asthma Treatment Market Size by Application
9.3.1 Asia Medicines for Eosinophilic Asthma Treatment Market Size by Application (2018-2024)
9.3.2 Asia Medicines for Eosinophilic Asthma Treatment Market Size by Application (2024-2029)
9.3.3 Asia Medicines for Eosinophilic Asthma Treatment Market Share by Application (2018-2029)
9.4 Asia Medicines for Eosinophilic Asthma Treatment Market Size by Region
9.4.1 Asia Medicines for Eosinophilic Asthma Treatment Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Medicines for Eosinophilic Asthma Treatment Market Size by Region (2018-2024)
9.4.3 Asia Medicines for Eosinophilic Asthma Treatment Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Medicines for Eosinophilic Asthma Treatment Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Medicines for Eosinophilic Asthma Treatment Market Size by Type
10.2.1 Middle East, Africa, and Latin America Medicines for Eosinophilic Asthma Treatment Market Size by Type (2018-2024)
10.2.2 Middle East, Africa, and Latin America Medicines for Eosinophilic Asthma Treatment Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Medicines for Eosinophilic Asthma Treatment Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Medicines for Eosinophilic Asthma Treatment Market Size by Application
10.3.1 Middle East, Africa, and Latin America Medicines for Eosinophilic Asthma Treatment Market Size by Application (2018-2024)
10.3.2 Middle East, Africa, and Latin America Medicines for Eosinophilic Asthma Treatment Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Medicines for Eosinophilic Asthma Treatment Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Medicines for Eosinophilic Asthma Treatment Market Size by Country
10.4.1 Middle East, Africa, and Latin America Medicines for Eosinophilic Asthma Treatment Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Medicines for Eosinophilic Asthma Treatment Market Size by Country (2018-2024)
10.4.3 Middle East, Africa, and Latin America Medicines for Eosinophilic Asthma Treatment Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 AstraZeneca
11.1.1 AstraZeneca Company Details
11.1.2 AstraZeneca Business Overview
11.1.3 AstraZeneca Medicines for Eosinophilic Asthma Treatment Introduction
11.1.4 AstraZeneca Revenue in Medicines for Eosinophilic Asthma Treatment Business (2018-2024)
11.1.5 AstraZeneca Recent Developments
11.2 GSK
11.2.1 GSK Company Details
11.2.2 GSK Business Overview
11.2.3 GSK Medicines for Eosinophilic Asthma Treatment Introduction
11.2.4 GSK Revenue in Medicines for Eosinophilic Asthma Treatment Business (2018-2024)
11.2.5 GSK Recent Developments
11.3 Genentech (Roche Group) & Novartis
11.3.1 Genentech (Roche Group) & Novartis Company Details
11.3.2 Genentech (Roche Group) & Novartis Business Overview
11.3.3 Genentech (Roche Group) & Novartis Medicines for Eosinophilic Asthma Treatment Introduction
11.3.4 Genentech (Roche Group) & Novartis Revenue in Medicines for Eosinophilic Asthma Treatment Business (2018-2024)
11.3.5 Genentech (Roche Group) & Novartis Recent Developments
11.4 Regeneron Pharmaceuticals & Sanofi
11.4.1 Regeneron Pharmaceuticals & Sanofi Company Details
11.4.2 Regeneron Pharmaceuticals & Sanofi Business Overview
11.4.3 Regeneron Pharmaceuticals & Sanofi Medicines for Eosinophilic Asthma Treatment Introduction
11.4.4 Regeneron Pharmaceuticals & Sanofi Revenue in Medicines for Eosinophilic Asthma Treatment Business (2018-2024)
11.4.5 Regeneron Pharmaceuticals & Sanofi Recent Developments
11.5 Teva Pharmaceuticals
11.5.1 Teva Pharmaceuticals Company Details
11.5.2 Teva Pharmaceuticals Business Overview
11.5.3 Teva Pharmaceuticals Medicines for Eosinophilic Asthma Treatment Introduction
11.5.4 Teva Pharmaceuticals Revenue in Medicines for Eosinophilic Asthma Treatment Business (2018-2024)
11.5.5 Teva Pharmaceuticals Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Medicines for Eosinophilic Asthma Treatment Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Fasenra
Table 3. Key Players of Nucala
Table 4. Key Players of Cinqair
Table 5. Key Players of Others
Table 6. Global Medicines for Eosinophilic Asthma Treatment Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 7. Global Medicines for Eosinophilic Asthma Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 8. Global Medicines for Eosinophilic Asthma Treatment Market Size by Region (2018-2024) & (US$ Million)
Table 9. Global Medicines for Eosinophilic Asthma Treatment Market Share by Region (2018-2024)
Table 10. Global Medicines for Eosinophilic Asthma Treatment Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 11. Global Medicines for Eosinophilic Asthma Treatment Market Share by Region (2024-2029)
Table 12. Medicines for Eosinophilic Asthma Treatment Market Trends
Table 13. Medicines for Eosinophilic Asthma Treatment Market Drivers
Table 14. Medicines for Eosinophilic Asthma Treatment Market Challenges
Table 15. Medicines for Eosinophilic Asthma Treatment Market Restraints
Table 16. Global Medicines for Eosinophilic Asthma Treatment Revenue by Players (2018-2024) & (US$ Million)
Table 17. Global Medicines for Eosinophilic Asthma Treatment Revenue Share by Players (2018-2024)
Table 18. Global Top Medicines for Eosinophilic Asthma Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Medicines for Eosinophilic Asthma Treatment as of 2022)
Table 19. Global Medicines for Eosinophilic Asthma Treatment Industry Ranking 2021 VS 2022 VS 2024
Table 20. Global 5 Largest Players Market Share by Medicines for Eosinophilic Asthma Treatment Revenue (CR5 and HHI) & (2018-2024)
Table 21. Global Key Players of Medicines for Eosinophilic Asthma Treatment, Headquarters and Area Served
Table 22. Global Key Players of Medicines for Eosinophilic Asthma Treatment, Product and Application
Table 23. Global Key Players of Medicines for Eosinophilic Asthma Treatment, Product and Application
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Medicines for Eosinophilic Asthma Treatment Market Size by Type (2018-2024) & (US$ Million)
Table 26. Global Medicines for Eosinophilic Asthma Treatment Revenue Market Share by Type (2018-2024)
Table 27. Global Medicines for Eosinophilic Asthma Treatment Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 28. Global Medicines for Eosinophilic Asthma Treatment Revenue Market Share by Type (2024-2029)
Table 29. Global Medicines for Eosinophilic Asthma Treatment Market Size by Application (2018-2024) & (US$ Million)
Table 30. Global Medicines for Eosinophilic Asthma Treatment Revenue Share by Application (2018-2024)
Table 31. Global Medicines for Eosinophilic Asthma Treatment Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 32. Global Medicines for Eosinophilic Asthma Treatment Revenue Share by Application (2024-2029)
Table 33. North America Medicines for Eosinophilic Asthma Treatment Market Size by Type (2018-2024) & (US$ Million)
Table 34. North America Medicines for Eosinophilic Asthma Treatment Market Size by Type (2024-2029) & (US$ Million)
Table 35. North America Medicines for Eosinophilic Asthma Treatment Market Size by Application (2018-2024) & (US$ Million)
Table 36. North America Medicines for Eosinophilic Asthma Treatment Market Size by Application (2024-2029) & (US$ Million)
Table 37. North America Medicines for Eosinophilic Asthma Treatment Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 38. North America Medicines for Eosinophilic Asthma Treatment Market Size by Country (2018-2024) & (US$ Million)
Table 39. North America Medicines for Eosinophilic Asthma Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 40. Europe Medicines for Eosinophilic Asthma Treatment Market Size by Type (2018-2024) & (US$ Million)
Table 41. Europe Medicines for Eosinophilic Asthma Treatment Market Size by Type (2024-2029) & (US$ Million)
Table 42. Europe Medicines for Eosinophilic Asthma Treatment Market Size by Application (2018-2024) & (US$ Million)
Table 43. Europe Medicines for Eosinophilic Asthma Treatment Market Size by Application (2024-2029) & (US$ Million)
Table 44. Europe Medicines for Eosinophilic Asthma Treatment Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 45. Europe Medicines for Eosinophilic Asthma Treatment Market Size by Country (2018-2024) & (US$ Million)
Table 46. Europe Medicines for Eosinophilic Asthma Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 47. China Medicines for Eosinophilic Asthma Treatment Market Size by Type (2018-2024) & (US$ Million)
Table 48. China Medicines for Eosinophilic Asthma Treatment Market Size by Type (2024-2029) & (US$ Million)
Table 49. China Medicines for Eosinophilic Asthma Treatment Market Size by Application (2018-2024) & (US$ Million)
Table 50. China Medicines for Eosinophilic Asthma Treatment Market Size by Application (2024-2029) & (US$ Million)
Table 51. Asia Medicines for Eosinophilic Asthma Treatment Market Size by Type (2018-2024) & (US$ Million)
Table 52. Asia Medicines for Eosinophilic Asthma Treatment Market Size by Type (2024-2029) & (US$ Million)
Table 53. Asia Medicines for Eosinophilic Asthma Treatment Market Size by Application (2018-2024) & (US$ Million)
Table 54. Asia Medicines for Eosinophilic Asthma Treatment Market Size by Application (2024-2029) & (US$ Million)
Table 55. Asia Medicines for Eosinophilic Asthma Treatment Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 56. Asia Medicines for Eosinophilic Asthma Treatment Market Size by Region (2018-2024) & (US$ Million)
Table 57. Asia Medicines for Eosinophilic Asthma Treatment Market Size by Region (2024-2029) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Medicines for Eosinophilic Asthma Treatment Market Size by Type (2018-2024) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Medicines for Eosinophilic Asthma Treatment Market Size by Type (2024-2029) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Medicines for Eosinophilic Asthma Treatment Market Size by Application (2018-2024) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Medicines for Eosinophilic Asthma Treatment Market Size by Application (2024-2029) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Medicines for Eosinophilic Asthma Treatment Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 63. Middle East, Africa, and Latin America Medicines for Eosinophilic Asthma Treatment Market Size by Country (2018-2024) & (US$ Million)
Table 64. Middle East, Africa, and Latin America Medicines for Eosinophilic Asthma Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 65. AstraZeneca Company Details
Table 66. AstraZeneca Business Overview
Table 67. AstraZeneca Medicines for Eosinophilic Asthma Treatment Product
Table 68. AstraZeneca Revenue in Medicines for Eosinophilic Asthma Treatment Business (2018-2024) & (US$ Million)
Table 69. AstraZeneca Recent Developments
Table 70. GSK Company Details
Table 71. GSK Business Overview
Table 72. GSK Medicines for Eosinophilic Asthma Treatment Product
Table 73. GSK Revenue in Medicines for Eosinophilic Asthma Treatment Business (2018-2024) & (US$ Million)
Table 74. GSK Recent Developments
Table 75. Genentech (Roche Group) & Novartis Company Details
Table 76. Genentech (Roche Group) & Novartis Business Overview
Table 77. Genentech (Roche Group) & Novartis Medicines for Eosinophilic Asthma Treatment Product
Table 78. Genentech (Roche Group) & Novartis Revenue in Medicines for Eosinophilic Asthma Treatment Business (2018-2024) & (US$ Million)
Table 79. Genentech (Roche Group) & Novartis Recent Developments
Table 80. Regeneron Pharmaceuticals & Sanofi Company Details
Table 81. Regeneron Pharmaceuticals & Sanofi Business Overview
Table 82. Regeneron Pharmaceuticals & Sanofi Medicines for Eosinophilic Asthma Treatment Product
Table 83. Regeneron Pharmaceuticals & Sanofi Revenue in Medicines for Eosinophilic Asthma Treatment Business (2018-2024) & (US$ Million)
Table 84. Regeneron Pharmaceuticals & Sanofi Recent Developments
Table 85. Teva Pharmaceuticals Company Details
Table 86. Teva Pharmaceuticals Business Overview
Table 87. Teva Pharmaceuticals Medicines for Eosinophilic Asthma Treatment Product
Table 88. Teva Pharmaceuticals Revenue in Medicines for Eosinophilic Asthma Treatment Business (2018-2024) & (US$ Million)
Table 89. Teva Pharmaceuticals Recent Developments
Table 90. Research Programs/Design for This Report
Table 91. Key Data Information from Secondary Sources
Table 92. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Medicines for Eosinophilic Asthma Treatment Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Medicines for Eosinophilic Asthma Treatment Market Share by Type: 2022 VS 2029
Figure 3. Fasenra Features
Figure 4. Nucala Features
Figure 5. Cinqair Features
Figure 6. Others Features
Figure 7. Global Medicines for Eosinophilic Asthma Treatment Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 8. Global Medicines for Eosinophilic Asthma Treatment Market Share by Application: 2022 VS 2029
Figure 9. Children Case Studies
Figure 10. Adults Case Studies
Figure 11. Teenagers Case Studies
Figure 12. Medicines for Eosinophilic Asthma Treatment Report Years Considered
Figure 13. Global Medicines for Eosinophilic Asthma Treatment Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 14. Global Medicines for Eosinophilic Asthma Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Medicines for Eosinophilic Asthma Treatment Market Share by Region: 2022 VS 2029
Figure 16. Global Medicines for Eosinophilic Asthma Treatment Market Share by Players in 2022
Figure 17. Global Top Medicines for Eosinophilic Asthma Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Medicines for Eosinophilic Asthma Treatment as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Medicines for Eosinophilic Asthma Treatment Revenue in 2022
Figure 19. North America Medicines for Eosinophilic Asthma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. North America Medicines for Eosinophilic Asthma Treatment Market Share by Type (2018-2029)
Figure 21. North America Medicines for Eosinophilic Asthma Treatment Market Share by Application (2018-2029)
Figure 22. North America Medicines for Eosinophilic Asthma Treatment Market Share by Country (2018-2029)
Figure 23. United States Medicines for Eosinophilic Asthma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Canada Medicines for Eosinophilic Asthma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Europe Medicines for Eosinophilic Asthma Treatment Market Size YoY (2018-2029) & (US$ Million)
Figure 26. Europe Medicines for Eosinophilic Asthma Treatment Market Share by Type (2018-2029)
Figure 27. Europe Medicines for Eosinophilic Asthma Treatment Market Share by Application (2018-2029)
Figure 28. Europe Medicines for Eosinophilic Asthma Treatment Market Share by Country (2018-2029)
Figure 29. Germany Medicines for Eosinophilic Asthma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. France Medicines for Eosinophilic Asthma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. U.K. Medicines for Eosinophilic Asthma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Italy Medicines for Eosinophilic Asthma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Russia Medicines for Eosinophilic Asthma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Nordic Countries Medicines for Eosinophilic Asthma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. China Medicines for Eosinophilic Asthma Treatment Market Size YoY (2018-2029) & (US$ Million)
Figure 36. China Medicines for Eosinophilic Asthma Treatment Market Share by Type (2018-2029)
Figure 37. China Medicines for Eosinophilic Asthma Treatment Market Share by Application (2018-2029)
Figure 38. Asia Medicines for Eosinophilic Asthma Treatment Market Size YoY (2018-2029) & (US$ Million)
Figure 39. Asia Medicines for Eosinophilic Asthma Treatment Market Share by Type (2018-2029)
Figure 40. Asia Medicines for Eosinophilic Asthma Treatment Market Share by Application (2018-2029)
Figure 41. Asia Medicines for Eosinophilic Asthma Treatment Market Share by Region (2018-2029)
Figure 42. Japan Medicines for Eosinophilic Asthma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. South Korea Medicines for Eosinophilic Asthma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. China Taiwan Medicines for Eosinophilic Asthma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Southeast Asia Medicines for Eosinophilic Asthma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. India Medicines for Eosinophilic Asthma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Australia Medicines for Eosinophilic Asthma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Middle East, Africa, and Latin America Medicines for Eosinophilic Asthma Treatment Market Size YoY (2018-2029) & (US$ Million)
Figure 49. Middle East, Africa, and Latin America Medicines for Eosinophilic Asthma Treatment Market Share by Type (2018-2029)
Figure 50. Middle East, Africa, and Latin America Medicines for Eosinophilic Asthma Treatment Market Share by Application (2018-2029)
Figure 51. Middle East, Africa, and Latin America Medicines for Eosinophilic Asthma Treatment Market Share by Country (2018-2029)
Figure 52. Brazil Medicines for Eosinophilic Asthma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. Mexico Medicines for Eosinophilic Asthma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. Turkey Medicines for Eosinophilic Asthma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. Saudi Arabia Medicines for Eosinophilic Asthma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. Israel Medicines for Eosinophilic Asthma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 57. GCC Countries Medicines for Eosinophilic Asthma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 58. AstraZeneca Revenue Growth Rate in Medicines for Eosinophilic Asthma Treatment Business (2018-2024)
Figure 59. GSK Revenue Growth Rate in Medicines for Eosinophilic Asthma Treatment Business (2018-2024)
Figure 60. Genentech (Roche Group) & Novartis Revenue Growth Rate in Medicines for Eosinophilic Asthma Treatment Business (2018-2024)
Figure 61. Regeneron Pharmaceuticals & Sanofi Revenue Growth Rate in Medicines for Eosinophilic Asthma Treatment Business (2018-2024)
Figure 62. Teva Pharmaceuticals Revenue Growth Rate in Medicines for Eosinophilic Asthma Treatment Business (2018-2024)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries